SkinHealth Systems Inc. 8-K

What Happened

• SkinHealth Systems Inc. (formerly The Beauty Health Company) filed an 8‑K reporting a Delaware certificate of amendment to change its name to SkinHealth Systems Inc., effective 12:01 a.m. ET on April 22, 2026. The company also filed a restated certificate of incorporation and amended and restated bylaws to reflect the name change and other governance updates.
• On April 17, 2026 the Board appointed three independent directors — Kenneth Tripp, Sachin Shridharani, MD, and E. Scott Beattie — increasing the board from nine to eleven members effective that date. Committee assignments: Mr. Tripp (Audit Committee), Dr. Shridharani (Nominating & Corporate Governance Committee), Mr. Beattie (Compensation Committee).
• The Board consulted with directors Desiree Gruber and Dr. Philippe Schaison and decided not to nominate them for reelection at the 2026 annual meeting; both will serve until their terms expire at the adjournment of that meeting. After the 2026 annual meeting, the Board expects to have nine directors.

Key Details

• Name change effective: April 22, 2026 at 12:01 a.m. ET; no stockholder vote was required and stockholder rights are unchanged.
• Board appointments effective: April 17, 2026 — Kenneth Tripp (former senior operations leader at Zimmer Biomet), Sachin Shridharani, MD (board‑certified plastic surgeon and CMO of SkinSpirit Essential), E. Scott Beattie (consumer‑products executive, former CEO of Elizabeth Arden).
• Governance updates in the amended bylaws include procedural changes (stockholder list examination timing), a new Rule 14a‑19 compliance clause for nominating stockholders, revised term language for directors appointed to new directorships (hold until next annual meeting), and other housekeeping updates.
• Director compensation will follow the company’s previously disclosed non‑employee director arrangements and be prorated to start dates; each new director will sign the company’s standard indemnification agreement.

Why It Matters

• The name change formalizes a rebrand to SkinHealth Systems Inc., which investors should note for filings and communications going forward. The filing says the change does not alter stockholder rights.
• The board additions bring experience in medical devices/manufacturing, aesthetic medicine, and global beauty/consumer brands, and fill key committee roles (Audit, Compensation, Nominating). That can influence oversight of strategy, product development and compliance.
• Bylaw changes affect nomination procedures and the terms for newly appointed directors, which are governance items investors may monitor for impacts on board composition and shareholder nomination rights.
• The 8‑K does not report any immediate financial measures or material contracts tied to these actions.